Literature DB >> 9315531

Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.

E Van Belle1, C Bauters, E Hubert, J C Bodart, K Abolmaali, T Meurice, E P McFadden, J M Lablanche, M E Bertrand.   

Abstract

BACKGROUND: Diabetes is a major risk factor for restenosis after coronary balloon angioplasty. Recent studies have shown that coronary stenting significantly reduces restenosis compared with balloon angioplasty alone. However, limited information is available on the effect of coronary stenting in diabetic patients. METHODS AND
RESULTS: We designed this study to analyze the effect of diabetes on restenosis in patients treated with either balloon angioplasty or coronary stenting who were enrolled in a 6-month angiographic follow-up program. Three hundred consecutive patients, 19% of whom were diabetics, who underwent coronary stent implantation during a single-vessel procedure on native coronary vessels and who had 6-month angiographic follow-up constituted the study group (stent group). Three hundred consecutive patients who underwent 6-month angiographic follow-up after single-vessel conventional balloon angioplasty served as control patients (balloon group). Preprocedural, postprocedural, and follow-up angiograms were analyzed with quantitative angiography. In the balloon group, the restenosis rate was almost twofold higher in diabetic than in nondiabetic patients (63% versus 36%; P=.0002) owing to both a greater late loss (0.79+/-0.70 versus 0.41+/-0.61 mm, respectively; P<.0001) and a higher rate of late vessel occlusion (14% versus 3%, respectively; P<.001). In the stent group, restenosis rates were similar in diabetics and nondiabetics (25% versus 27%, respectively). Furthermore, in the stent group, late loss (0.77+/-0.65 versus 0.79+/-0.57 mm, respectively) and the rate of late vessel occlusion (2% versus 1%, respectively) did not differ significantly between diabetic and nondiabetic patients.
CONCLUSIONS: Although diabetics have increased rates of restenosis and late vessel occlusion after simple balloon angioplasty, they have the same improved outcome with coronary stenting that has been documented in nondiabetic patients.

Entities:  

Mesh:

Year:  1997        PMID: 9315531     DOI: 10.1161/01.cir.96.5.1454

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

Review 1.  Revascularization strategies in patients with diabetes: evolving concepts.

Authors:  J J Brennan; H S Cabin
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease?

Authors:  A Kapur; I S Malik
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

3.  Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat.

Authors:  Xiaoyong Tong; Xiuyun Hou; David Jourd'heuil; Robert M Weisbrod; Richard A Cohen
Journal:  Circ Res       Date:  2010-08-19       Impact factor: 17.367

4.  Role of drug eluting stents in diabetic patients.

Authors:  F Boccara; E Teiger; A Cohen
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

Review 5.  A risk-benefit assessment of abciximab in angioplasty.

Authors:  N S Kleiman
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 6.  [Pathophysiology and therapeutic concepts in coronary restenosis].

Authors:  H G Klues; P W Radke; R Hoffmann; J vom Dahl
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

Review 7.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

8.  Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention.

Authors:  J R S Day; I S Malik; A Weerasinghe; M Poullis; I Nadra; D O Haskard; K M Taylor; R C Landis
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 9.  Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention.

Authors:  K P Morgan; A Kapur; K J Beatt
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

10.  Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients.

Authors:  Eui-Young Choi; Hyuck Moon Kwon; Chul-Woo Ahn; Geun Taek Lee; Boyoung Joung; Bum Kee Hong; Young Won Yoon; Dongsoo Kim; Ki-Hyun Byun; Tae Soo Kang; Se-Jung Yoon; Sung Woo Kwon; Sung-Ju Lee; Jong-Kwan Park; Hyun-Seung Kim
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.